SCHEMBL14243124

SCHEMBL14243124

NC(=O)/C(=C/c1cnn2c(NC3CC3)cc(N)nc12)NC=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2B P67870 3/20 0.48
BCL6 P41182 2/20 0.37
KCNH2 Q12809 5/20 0.34
CSNK2A1 P68400 11/20 0.33
CSNK2A2 P19784 2/20 0.33
TYK2 P29597 1/20 0.33
CDK2 P24941 3/20 0.32
CCNT1 O60563 1/20 0.32
CDK1 P06493 1/20 0.32
CDK4 P11802 1/20 0.32
CCNA2 P20248 1/20 0.32
CCND1 P24385 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK7 P50613 1/20 0.32
CDK9 P50750 1/20 0.32
CCNH P51946 1/20 0.32
CCNA1 P78396 1/20 0.32
CDK3 Q00526 1/20 0.32
CDK6 Q00534 1/20 0.32
CDK5 Q00535 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14242464 0.86 CSNK2B (0.44) CSNK2BBCL6KCNH2CSNK2A1CSNK2A2
SCHEMBL14242544 0.86 CSNK2B (0.51) CSNK2BBCL6KCNH2CSNK2A1CSNK2A2
SCHEMBL14243301 0.84 CSNK2B (0.48) CSNK2BKCNH2CSNK2A1CSNK2A2TYK2
SCHEMBL14242542 0.82 CSNK2B (0.40) CSNK2BBCL6CSNK2A1
SCHEMBL2028655 0.81 CSNK2B (0.69) CSNK2BBCL6CSNK2A1CSNK2A2CDK2
SCHEMBL14242545 0.81 CSNK2A1 (0.41) CSNK2BBCL6KCNH2CSNK2A1CSNK2A2
SCHEMBL14243294 0.80 CSNK2B (0.45) CSNK2BKCNH2CSNK2A1CSNK2A2TYK2
SCHEMBL14242539 0.79 CSNK2B (0.44) CSNK2BKCNH2CSNK2A1CSNK2A2TYK2
SCHEMBL14242540 0.78 CSNK2B (0.37) CSNK2BCSNK2A1CSNK2A2TYK2CCNT1
SCHEMBL14242596 0.77 CSNK2B (0.40) CSNK2BKCNH2CSNK2A1CSNK2A2TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012170827-A2 PYRAZOLOPYRIMIDINES AND RELATED HETEROCYCLES AS CK2 INHIBITORS CYLENE PHARMACEUTICALS, INC. (US) 2012-12-13 WO disclosed